A clinicopathologic and molecular analysis of five cases of bronchiolar adenoma with rare mutations

Bronchiolar adenoma (BA) is a rare benign lung tumor that shows proliferation of bland bronchiolar-type epithelium containing a continuous layer of basal cells. This tumor entity has been newly added to the recent World Health Organization (WHO) classification 5th edition. This entity encompasses a spectrum of lesions: the classic ciliated muconodular papillary tumor (CMPT) and the non-classic CMPT. Although BA is reported to have driver mutations including BRAF V600E, EGFR, and KRAS, the molecular profile of BA is still incompletely understood. Five resected BAs at our institutions were analyzed. The BA lesions were subdivided into two groups: three proximal-type BAs and two distal-type BAs. NRAS codon 12/13 mutation and EML4 exon 20-ALK exon 20 fusion were found in two of the three proximal-types. BRAF V600E mutation was found in one of the two distal-types. Two cases coexisted with lung adenocarcinoma, with EGFR exon 19 deletion and KRAS mutation, respectively. No recurrence was observed at a median of 12 months (range 2-84 months) of follow-up. BA has uncommon variants of mutation seen in lung adenocarcinoma. NRAS mutation and ALK fusion partner has not been reported previously. The present cases may reinforce the distinctive biology of BA from lung adenocarcinoma.

High sensitive troponin T as gatekeeper for cardiac magnetic resonance imaging in patients with suspected acute myocarditis

Background

The diagnosis of acute (AM) is difficult because of the variable, unspecific clinical presentation. Cardiac magnetic resonance (CMR) is the noninvasive gold standard diagnostic tool, but limited availability and high costs make a quick and inexpensive test necessary to clarify the need for CMR. Quantification of high sensitive Troponin T (hsTNT) is a broadly available, specific blood test for cardiomyocyte damage.

Aim

The aim of this study was to evaluate hsTNT as a gatekeeper for CMR with a lower cut off-value for exclusion and an upper cut-off value for confirmation of acute myocarditis as defined by CMR.

Methods

This retrospective analysis included 244 patients (age 39±17 years, 71% male) who received CMR for clinically suspected AM and quantification of hsTNT within 28 days (Median: 2 days) of CMR. CMR (1.5 Tesla) consisted of cine-sequences, edema-sensitive T2 and late gadolinium enhancement (LGE) imaging. AM was diagnosed in presence of both, myocardial edema and LGE consistent with acute myocarditis.

Results

Of 244 patients, 78 (32%) were CMR-positive (CMR+) for AM. 166 (68%) were CMR negative (CMR−). Mean hsTNT was 206±454 pg/ml.

HsTNT was significantly higher in CMR+ than in CMR− (604±639 pg/ml vs 20±56 pg/ml, p<0.001, see figure A). 8 CMR+ patients (10%) had hsTNT in the normal range (<14 ng/ml).

HsTNT showed good discriminatory performance in the Receiver Operator Characteristic (ROC) analysis (AUC 0.91, see figure B).

A lower cut-off value of 4 pg/ml had a sensitivity of 98.7% for diagnosis of AM (hsTNT ≥4 pg/ml) and a negative predictive value of 98.2% for rule out of AM (hsTNT<4 pg/ml) as defined by CMR, leading to a reduction of 23.4% of CMR exams. An upper cut-off value of >343 pg/ml had a specificity of 99.4% and positive predictive value of 97.8% for diagnosis of AM, leading to a reduction of 18.4% of CMR exams (see table).

Conclusions

hsTNT showed good discriminatory capacity for acute myocarditis (AM) as defined by CMR. However, 10% of patients had hsTNT in the normal range (<14 pg/ml). A lower cut-off value of <4 pg/ml ruled out AM with very high negative predictive value, whereas an upper cut-off of >343 pg/ml had a very high positive predictive value for confirmation of AM as defined by CMR. Performing CMR only in patients with hsTNT between 4 and 343 pg/ml would have led to a reduction of 41.8% of CMR exams.

Funding Acknowledgement

Type of funding source: None

Advanced G-CSF-producing non-small cell lung cancer-not otherwise specified, with favourable response to pembrolizumab monotherapy

Advanced granulocyte colony-stimulating factor (G-CSF)-producing lung tumours are generally refractory to platinum-based chemotherapy and are associated with poor prognosis. However, therapeutic strategies for these tumours remain unknown. A 74-year-old man was diagnosed with non-small cell lung cancer-not otherwise specified (NSCLC-NOS); the clinical stage was T4N0M1c stage IVb. Blood testing showed leucocytosis and aberrant G-CSF expression. We chose single-agent pembrolizumab as the initial treatment because PD-L1 was highly expressed in the tumours. A clinically favourable response was achieved from seven courses of pembrolizumab with a total disease-free survival of 10 months. During this period, the blood leucocyte count was concordant with the disease condition. These observations showed that pembrolizumab monotherapy may be an effective treatment for patients with advanced G-CSF-producing NSCLC-NOS and that the monitoring of leucocyte count may be a useful biomarker for predicting the efficacy of pembrolizumab monotherapy.

Risk model for severe postoperative complications after total pancreatectomy based on a nationwide clinical database

BACKGROUND

Total pancreatectomy is required to completely clear tumours that are locally advanced or located in the centre of the pancreas. However, reports describing clinical outcomes after total pancreatectomy are rare. The aim of this retrospective observational study was to assess clinical outcomes following total pancreatectomy using a nationwide registry and to create a risk model for severe postoperative complications.

METHODS

Patients who underwent total pancreatectomy from 2013 to 2017, and who were recorded in the Japan Society of Gastroenterological Surgery and Japanese Society of Hepato-Biliary-Pancreatic Surgery database, were included. Severe complications at 30 days were defined as those with a Clavien-Dindo grade III needing reoperation, or grade IV-V. Occurrence of severe complications was modelled using data from patients treated from 2013 to 2016, and the accuracy of the model tested among patients from 2017 using c-statistics and a calibration plot.

RESULTS

A total of 2167 patients undergoing total pancreatectomy were included. Postoperative 30-day and in-hospital mortality rates were 1·0 per cent (22 of 2167 patients) and 2·7 per cent (58 of 167) respectively, and severe complications developed in 6·0 per cent (131 of 2167). Factors showing a strong positive association with outcome in this risk model were the ASA performance status grade and combined arterial resection. In the test cohort, the c-statistic of the model was 0·70 (95 per cent c.i. 0·59 to 0·81).

CONCLUSION

The risk model may be used to predict severe complications after total pancreatectomy.

P2742Right ventricular stroke volume during dobutamine stress magnetic resonance compared to lung perfusion and peak oxygen uptake after arterial switch operation for transposition of the great arteries

Objectives

Abnormal pulmonary perfusion due to stenosis of the central pulmonary arteries is common after neonatal arterial switch operation (ASO) for transposition of the great arteries (TGA). We conducted a monocentric prospective study in young adults after neonatal ASO for TGA to evaluate the effects of abnormal pulmonary perfusion on the increase of the right ventricular stroke volume (RVSV) during dobutamine stress magnetic resonance (DSMR) and on cardiopulmonary exercise capacity.

Methods

68 unselected patients (age 18–29 years) underwent CMR at rest and under dobutamine stress (10 to 40 μg/kg/min). RVSV, pulmonary blood flow distribution (PBFD) and peak flow velocity were derived from phase contrast mapping in the main, right and left pulmonary artery (PA) at rest and each stress level. A cardiopulmonary exercise test (CPET) was performed at the same day. All patients reached maximal exercise effort according to heart rate and respiratory exchange rate.

Results

PBFD at rest: 9/68 patients (13%, ASO-S) had abnormal pulmonary perfusion at rest, defined as PBFD >2:1 (right/left or left/right) and/or relevant stenosis of the main PA (Vmax >2.5 m/s). 59/68 patients (87%, ASO-N) had normal pulmonary perfusion.

PBFD under DSMR: (1) In the whole patient group, there was no increase of PBFD under stress compared to PBFD at rest. On an individual patient level, no relevant worsening of abnormal PBFD was found.

(2) Under low dose dobutamine, ASO-S had a significantly lower RVSV-increase (RVSVstress/RVSVrest) compared to ASO-N (see figure). However, under high dose dobutamine, this effect was no longer significant (see figure).

(3) The RVSV-increase under low and high dose dobutamine did not correlate with peak oxygen uptake during CPET, neither in the total group nor in the subgroups (see table). Peak oxygen uptake was not significantly different between ASO-N and ASO-S (p=0,72).

RVSV-increase compared to CPET peak VO2% ASO-total ASO-S ASO-N RVSV-increase/peak VO2% RVSV-increase/peak VO2% RVSV-increase/peak VO2% low dose dobu high dose dobu low dose dobu high dose dobu low dose dobu high dose dobu Pearson correlation coefficient −0.02 −0.05 0.01 −0.22 −0.05 −0.04 p-value 0.90 0.71 0.98 0.56 0.71 0.78

Figure 1

Conclusion

(1) Patients with relevant stenosis of main PA and/or abnormal peripheral blood flow distribution (ASO-S) exhibit a reduced RVSV-increase under low dose dobutamine compared to patients without stenosis (ASO-N). This effect was not present under high dose dobutamine stress.

(2) These findings did not correlate with peak oxygen uptake during CPET, an objective parameter of cardiopulmonary exercise capacity.

(3) Therefore, a conservative proceeding rather than surgery or catheter intervention should be considered, especially in asymptomatic adult patients.

Acknowledgement/Funding

Supported by Kinderherzen, Fördergemeinschaft Deutsche Kinderherzzentren e.V.

Contribution to oral and maxillary surgery and surgical technique of osteo-odontokeratoprosthesis in Japan

Osteo-odontokeratoprosthesis (OOKP) is a technique invented by Strampelli in 1963, in which the patient's own tooth root is used to support an optical cylinder. It uses an autologous tooth-bone-periodontal complex to mount an optical cylinder, which is stabilised by overlying autologous buccal mucosa. OOKP involves two, staged procedures done by ophthalmologists and oral surgeons, and the main contribution from the oral surgeon is during the first stage. To date we have done nine first-stage, and completed eight second-stage, OOKP operations in Japan with a mean follow-up of eight years and 11 months by modifying the original method of the oral surgery. All OOKP procedures were unilateral, and canines were selected as the donor teeth. Patients developed ocular blindness as a result of Stevens-Johnson syndrome, ocular cicatricial pemphigoid, and chemical and thermal burns to the cornea and ocular surface. All eight patients who completed the second stage have been stable, and there have been no major perioperative or postoperative oral complications. The patients' visual acuities were stable with no serious complications. Here we report the technical details of the oral contribution to OOKP.

Proposal for a Safe and Functional Pancreaticojejunostomy Technique from a Histopathological Perspective

BACKGROUND

To prevent leakage of pancreatic juice from the main pancreatic duct (MPD), complete external drainage appears to be the most effective technique. However, because this requires a pancreatic stent tube to be ligated with MPD, duct-to-mucosa pancreaticojejunostomy (PJ) is difficult. From our histopathological examination, a large amount of pancreatic juice is drained from the ducts other than MPD. This study aimed to evaluate our new conceptual technique of PJ after pancreaticoduodenectomy (PD).

METHODS

We considered it important to drain pancreatic juice from the branch pancreatic ducts to the intestinal tract and to perform duct-to-mucosa PJ, while pancreatic juice from MPD is completely drained out of the body. We designed a technique that could simultaneously achieve these points. In our technique, which is based on conventional "two-row" anastomosis, a stent tube is fixed with MPD and its surrounding tissue by purse-string suture at the cut surface of the pancreas, and duct-to-mucosa PJ is concomitantly performed.

RESULTS

Of 45 patients undergoing PD, 12 of soft pancreas underwent surgery with this technique. According to the classification of the International Study Group on Pancreatic Fistula, a Grade A PF was observed in four patients, whereas no patient had a Grade B or C PF.

CONCLUSIONS

We propose our anastomotic technique that could simultaneously prevent PF and keep the pancreatic duct patent.

How useful are hemoglobin concentration and its variations to predict significant hemorrhage in the early phase of trauma? A multicentric cohort study

Background

The diagnostic value of hemoglobin (Hb) for detecting a significant hemorrhage (SH) in the early phase of trauma remains controversial. The present study aimed to assess the abilities of Hb measurements taken at different times throughout trauma management to identify patients with SH.

Methods

All consecutive adult trauma patients directly admitted to six French level-1 trauma centers with at least one prehospital Hb measurement were analyzed. The abilities of the following variables to identify SH (≥ 4 units of red blood cells in the first 6 h and/or death related to uncontrolled bleeding within 24 h) were determined and compared to that of shock index (SI): Hb as measured with a point-of-care (POC) device by the prehospital team on scene (POC-Hb_prehosp) and upon patient’s admission to the hospital (POC-Hb_hosp), the difference between POC-Hb_hosp and POC-Hb_prehosp (DeltaPOC-Hb) and Hb as measured by the hospital laboratory on admission (Hb-Lab_hosp).

Results

A total of 6402 patients were included, 755 with SH and 5647 controls (CL). POC-Hb_prehosp significantly predicted SH with an area under ROC curve (AUC) of 0.72 and best cutoff values of 12 g/dl for women and 13 g/dl for men. POC-Hb_prehosp < 12 g/dl had 90% specificity to predict of SH. POC-Hb_hosp and Hb-Lab_hosp (AUCs of 0.92 and 0.89, respectively) predicted SH better than SI (AUC = 0.77, p < 0.001); best cutoff values of POC-Hb_hosp were 10 g/dl for women and 12 g/dl for men. DeltaPOC-Hb also predicted SH with an AUC of 0.77, a best cutoff value of − 2 g/dl irrespective of the gender. For a same prehospital fluid volume infused, DeltaPOC-Hb was significantly larger in patients with significant hemorrhage than in controls.

Conclusions

Challenging the classical idea that early Hb measurement is not meaningful in predicting SH, POC-Hb_prehosp was able, albeit modestly, to predict significant hemorrhage. POC-Hb_hosp had a greater ability to predict SH when compared to shock index. For a given prehospital fluid volume infused, the magnitude of the Hb drop was significantly higher in patients with significant hemorrhage than in controls.

Electronic supplementary material

The online version of this article (10.1186/s13613-018-0420-8) contains supplementary material, which is available to authorized users.

Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway

Liver metabolism undergoes robust circadian oscillations in gene expression and enzymatic activity essential for liver homeostasis, but whether the circadian clock controls homeostatic self-renewal of hepatocytes is unknown. Here we show that hepatocyte polyploidization is markedly accelerated around the central vein, the site of permanent cell self-renewal, in mice deficient in circadian Period genes. In these mice, a massive accumulation of hyperpolyploid mononuclear and binuclear hepatocytes occurs due to impaired mitogen-activated protein kinase phosphatase 1 (Mkp1)-mediated circadian modulation of the extracellular signal-regulated kinase (Erk1/2) activity. Time-lapse imaging of hepatocytes suggests that the reduced activity of Erk1/2 in the midbody during cytokinesis results in abscission failure, leading to polyploidization. Manipulation of Mkp1 phosphatase activity is sufficient to change the ploidy level of hepatocytes. These data provide clear evidence that the Period genes not only orchestrate dynamic changes in metabolic activity, but also regulate homeostatic self-renewal of hepatocytes through Mkp1-Erk1/2 signaling pathway.

Circadian clock regulates hepatic gene expression and functions. Here Chao et al. show that alteration of circadian clock genes by Period deletion induces polyploidy in hepatocytes due to impaired regulation of Erk signaling by mitogen-activated protein kinase phosphatase 1.